Lv5
1476 积分 2023-12-25 加入
Updates in chronic graft-versus-host disease: novel treatments and best practices in the current era
1天前
待确认
The delicate balance of graft versus leukemia and graft versus host disease after allogeneic hematopoietic stem cell transplantation
3天前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
6天前
已完结
Pigmented Villonodular Synovitis: Current Concepts About Diagnosis and Management
7天前
已关闭
Risk of oral cancer in patients with graft-vs-host disease: A systematic review and meta-analysis
9天前
已关闭
Mitigating acute chemotherapy-associated adverse events in patients with cancer
10天前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
10天前
已完结
Aumolertinib with carboplatin–pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open‐label, multicenter, randomized phase 3 study
10天前
已完结
Chemotherapy in EGFR-mutated NSCLC: optimizing combinations with TKIs and amivantamab
13天前
已完结
EGFR -Mutated Lung Cancer — Letting the Butterfly Out of the Cocoon
13天前
已完结
皖公网安备34019202002308
